Back

Select your region

Arrange a consultation about stem cells

Learn more

Where are
stem cells used?

Development of stem cell therapy

The first successful use of umbilical cord blood cells took place in France in 1988. In 2007, cord blood from FamiCord resources was used for transplantation for the first time. Since then, cord blood stem cells have been transplanted more than 85,000 times worldwide, helping to save lives and restore health for thousands of patients.

As medicine continues to advance, the number of diseases that can be treated with stem cell transplantation is steadily increasing. Today, stem cell therapy is considered a standard treatment for many conditions according to the European Society for Blood and Marrow Transplantation (EBMT) guidelines.


Discover which diseases can be treated using cord blood stem cells and learn how these therapies are shaping the future of regenerative medicine.

List of diseases treated with stem cells

Acute leukaemias

acute lymphoblastic leukaemia (ALL)

acute myeloid leukaemia (AML)

acute biphenotipic leukaemia

poorly differentiated acute leukaemia

Chronic leukaemias

chronic myeloid leukaemia (CML)

chronic lymphocytic leukaemia (CLL)

juvenile chronic myeloid leukaemia (JCML)

juvenile myelomonocytic leukaemia (Naegeleg leukaemia) (JMML)

Myelodisplastic syndrome

refractory anaemia (RA)

refractory anaemia with ringed sideroblasts (RARS)

refractory anaemia with excess blasts (RAEB)

refractory anaemia with excess blasts in transformation (RAEB-T)

chronic myelomonocytic leukaemia (CMML)

Diseases caused by stem cell defect

aplastic anaemia(severe)

Fanconi anaemia

paroxysmal nocturnal haemoglobinuria

Myeloproliferative syndromes

acute myelofibrosis

myelofibrosis

polycythaemia vera

Essentials thromb ocythemia

Hyperplastic disorders of lymphatic system

non-Hodgkin lymphoma

acute lymphogranuloma

prolimphocytic leukaemia

Phagocytic disorders

Chediak-Higashi syndrome

chronic granulomatous disease (CGD)

neutrophil actin dysfunction

reticular dysgenesis

Disorders caused by the absence or malfunctioning of enzymes

mucopolysaccharidoses MPS)

Scheie syndrome (MPS-IS)

Hunter syndrome (MPS-II)

Sanfilippo syndrome (MPS-III)

Morquio syndrome (MPS-IV)

Maroteaux-Lamy syndrome (MPS-VI)

Sly syndrome, beta- glucoronidase deficiency (MPS-VII)

adrenoleukodystrophy

mucolipidosis II

Krabbe disease

Gaucher disease

Niemann-Pick disease

Wolman disease

metachromatic leukodystrophy

Histiocytic disorders

familial erythrophagocytic lymphohistiocytosis

histiocytosis -X

hemophagocytosis

Inherited red blood cell abnormalities

beta thalassemia

pure red cell aplasia

sickle cell anaemia

Inherited immune system disorders

telangiectasia

Kostmann syndrome

leukocyte adhesion deficiency

DiGeorge syndrome

bare lymphocyte syndrome

Omenn syndrome

severe combined immunodeficiency (SCID)

SCID adenosine deaminase deficiency

SCID T and B lymphocytes negative

SCID T lymphocytes negative and B lymphocytes positive

common variable immunodeficiency

Wiskotta Aldrich syndrome

X-linked lymphoproliferative disorder

Other inherited conditions

Lesch-Nyhan syndrome

cartilage-hair hypoplasia

Glanzmann’s thrombasthenia

osteopetrosis (marble bone disease)

Hereditary thrombotic disorders

mega-karyocytosis (inherited thrombocythemia)

Plasma cell disorders

multiple myeloma

plasmocythic leukaemia

Waldenström’s macroglobulinemia

Other forms of cancer

breast cancer

Ewing’s sarcoma

neuroblastoma (sympathicoblastoma)

kidney cancer

Icon

Stem cell therapy can also benefit patients with neurological conditions, including autism and infantile cerebral palsy, offering new hope for improved quality of life.